Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (Q36755367)

16 August 2017

1 reference

title

Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (English)

1 reference

16 August 2017

Alberto A Antunes

1

1 reference

16 August 2017

Miguel Srougi

series ordinal

2

1 reference

16 August 2017

Rafael F Coelho

series ordinal

3

1 reference

16 August 2017

Geraldo de Campos Freire

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

16 August 2017

published in

Nature Reviews Urology

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

155-160

1 reference

The development of human benign prostatic hyperplasia with age

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Long-Term Risk Of Re-Treatment Of Patients Using α-Blockers For Lower Urinary Tract Symptoms

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Antimuscarinic therapy in men with lower urinary tract symptoms: what is the evidence?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Emerging role of botulinum toxin in the management of voiding dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Systemic toxicity of botulinum toxin by intramuscular injection in the monkey

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

A focused review on the use of botulinum toxins for neuropathic pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Botulinum toxin A for spasticity, muscle spasms, and rigidity

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

The application of botulinum toxin in the prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Botox-induced prostatic involution

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Cholinergic innervation and function in the prostate gland

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Studies on the structure and intrinsic innervation of the normal human prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0735

7 January 2021

Identifiers

DOI

10.1038/NCPURO0735

1 reference

16 August 2017

1 reference